Vanguard Group Inc Vincerx Pharma, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 286,372 shares of VINC stock, worth $366,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
286,372
Previous 627,442
54.36%
Holding current value
$366,556
Previous $451,000
82.93%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VINC
# of Institutions
22Shares Held
5.48MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$2.18 Million0.1% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$1.14 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct674KShares$862,9670.0% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$808,1880.0% of portfolio
-
Armistice Capital, LLC New York, NY567KShares$725,7740.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $27.1M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...